ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

This adverse event was reported 7172 times

These drugs are most commonly taken by patients reporting ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE:

# Drug Count
0 LEFLUNOMIDE 6253
1 METHOTREXATE SODIUM 6217
2 ADALIMUMAB 6102
3 TOCILIZUMAB 5991
4 METHOTREXATE 5929
5 RITUXIMAB 5866
6 INFLIXIMAB 5784
7 DICLOFENAC SODIUM 5712
8 PREDNISONE 5708
9 SULFASALAZINE 5685
See all common drugs associated with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GOLIMUMAB 5486 0.4356
1 CAFFEINE CITRATE 931 0.3989
2 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 242 0.3678
3 CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL 103 0.3355
4 PSEUDOEPHEDRINE HCL 3642 0.3327
5 CORTISONE ACETATE 3947 0.3158
6 DESOXIMETASONE 5515 0.2861
7 TRIPROLIDINE HYDROCHLORIDE 47 0.2410
8 HYDROCORTISONE BUTYRATE 430 0.2176
9 DICLOFENAC POTASSIUM TABLETS 1794 0.2069
See all drugs enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 793 1.1526
1 Endoglycosidase [EPC] 240 0.1295
2 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 747 0.0856
3 Interleukin-17A Antagonist [EPC] 3015 0.0809
4 Provitamin D2 Compound [EPC] 2199 0.0739
5 Antirheumatic Agent [EPC] 6253 0.0591
6 Aminosalicylate [EPC] 5734 0.0569
7 Interleukin-6 Receptor Antagonist [EPC] 6111 0.0441
8 Selective T Cell Costimulation Modulator [EPC] 5524 0.0395
9 Interleukin-12 Antagonist [EPC] 3625 0.0349
See all drug classes enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE